Sin inscripción previa

Recorded content

Biotechnological development applied to the health field is progressing faster and faster and generates a greater impact on our daily lives. In the short term we are probably not aware but in the long term this is going to mean a total change in how we prevent and cure diseases. In fact, more and more authors agree that the next evolution of Homo Sapiens passes through its union with technology.

If you want to know more about this exciting topic, do not miss this table where we will know at what point in this evolution we are, what advances are happening at the moment or their results are open.



Beatriz Noya

PhD in Chemistry (University of Santiago de Compostela, 1996) and postdoctoral researcher in Germany until 2000. From 2000 to 2011, R&D personnel in different European biotech entities (countries: Sweden, Great Britain and Spain). After training in project management (MUPM, BES-LaSalle-URL, Barcelona), between 2014 and 2019 I collaborated as a consultant with Galician entities such as USC (in spin-offs; Biofarma group; sporadically with other IPs in support tasks for the preparation of proposals for H2020 calls) and the Kaertor Foundation (a “Global Initiative, pioneer in open innovation and public-private co-development in drug discovery.). Since April 2020, she at the University of Vigo as management staff for the European project GLAUKOS.



Pablo López

15 years of experience in technological innovation, in companies such as BOSCH, INDITEX, linked to technological innovation, later Innovation Consulting in SERVIGUIDE and INCOTEC. Advisor and Founder in startups foodtech, biotech, cybersecurity, blockchain, he participates in different networks of experts in project evaluation and acceleration.

In 2014 he came into contact with the cryptocurrency and blockchain environment in LATAM, developing different projects since then that has led him to advise on the design of blockchain architectures as well as business models and tokenomics. Founder of CreatiBlock, Blockchain Venture Builder for scale up and investment in projects that use blockchain technology.



Eldara Rodríguez

Doctor in Chemistry from the University of Santiago de Compostela with more than 15 years of research experience, first as a Researcher in the USC NANOMAG group and later in the private sector in the R&D Department of the company NANOGAP (spin-off of the USC dedicated to the development and manufacture of nanomaterials).

Enthusiast of Innovation and Technology Transfer, in 2006 he participated in the founding of NANOGAP and as of 2016 he became Head of Innovation, taking charge of the management of the subsidized projects of the company, as well as its intellectual property.



María Guix

Received her PhD in Chemistry, M.S. degree in Nanotechnology and B.Sc. degree in Chemistry from the Universitat Autònoma de Barcelona (UAB), at Prof. Merkoçi's group at Catalan Institute of Nanoscience and Nanotechnology (ICN2). She gained experience on the design of catalytic micromotors while working in EMPA (Switzerland), the University of California San Diego (USA) and at IFW Dresden (Germany). Afterwards, she joined Purdue University, where she worked on magnetic microrobots automation and since 2018 she is a postdoctoral researcher at the Institute for Bioengineering of Catalonia (Spain) focused on the development of advanced functional living robots.



In collaboration with:
Media Partners: